MedTrace Logo

Comparison on Outcomes of Four IOLs in Patients With Cataracts

NCT06590272 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 103

Last updated 2024-09-19

No results posted yet for this study

Summary

The objective of this study was to compare the objective visual outcomes and subjective fuctional vision of four different intraocular lens (IOL) in patients underwent cataracts surgery. This was a retrospective study. Patients with age-related cataract underwent phacoemulsification combined with IOLs implantation. Patients were divided into 4 groups. Uncorrected distant visual acuity(UDVA), uncorrected intermediate visual acuity (UIVA), uncorrected near visual acuity (UNVA),and the best corrected visual acuity (BCVA) 1 month and 3 months after the surgery were determined. The defocus curve, contrast sensitivity, and customized VF-14-oriented Visual Function Index questionnaire were performed 3 months postoperatively. Kruskal-Wallis test and generalized estimating equation(GEE) were used to analyze and compare the difference between objective visual outcomes and subjective visual quality among different groups.

Conditions

  • Cataract
  • Intraocular Lens
  • Visual Outcomes

Interventions

DEVICE

TECNIS PCB00 intraocular lens

In this study, we select TECNIS PCB00 IOL for inserting in the eyes during the cataract surgery

DEVICE

HumanOptics Diff-Aay intraocular lens

In this study, we select HumanOptics Diff-Aay IOL for inserting in the eyes during the cataract surgery

DEVICE

TECNIS Symfony ZXR00 intraocular len

In this study, we select TECNIS Symfony ZXR00 IOL for inserting in the eyes during the cataract surgery

DEVICE

ZEISS AT LISA tri 839MP intraocular len

In this study, we select ZEISS AT LISA tri 839MP IOL for inserting in the eyes during the cataract surgery

Sponsors & Collaborators

  • Shanghai 10th People's Hospital

    lead OTHER

Principal Investigators

  • Yiwen Hu · Shanghai 10th People's Hospital

Eligibility

Min Age
50 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06590272 on ClinicalTrials.gov